← Back to Patent Explorer
US4532343A Expired / Lapsed US ⏱️ 0.0 years remaining

Aromatic retinoic acid analogues

Assignee: SRI International Inc
•
Filing: 1982-11-19
•
Granted: 1985-07-30
•
Expires: 2002-11-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Aromatic retinoic acid analogues of the formula <IMAGE> where X is hydrogen or fluorine, Y is hydrogen, halogen of atomic number 9 or 17, hydroxy, alkyl of 1 to 2 carbon atoms or alkoxy of 1 to 2 carbon atoms and R is hydroxy, alkoxy, aroxy, or NR1R2 where R1 is hydrogen, alkyl, or aryl and R2 is alkyl or aryl, with the proviso that when Y is hydrogen, X is fluorine. These retinoids are useful as chemopreventive agents for inhibiting tumor promotion in epithelial cells and for treating nonmalignant skin disorders.

Inventors

  • 👤 Marcia I. Dawson
  • 👤 Peter D. Hobbs

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 11:17
CPC Classifications
C; C07; C07C; C07C403/00; C07C403/20; A; A61; A61P; A61P35/00; C07C2601/00; C07C2601/12; C07C2601/16

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 60 words
A compound of the formula: ##STR5## where X is H or F, Y is H, F, Cl, hydroxy, methyl, ethyl, methoxy or ethoxy, and R is hydroxyl, alkoxy, aroxy, or NR 1 R 2 where R 1 is hydrogen, alkyl, or aryl and R 2 is alkyl or aryl, with the proviso that when Y is H, X is F.
Claim 2
Dependent Claim 60 words
A compound of the formula: ##STR5## where X is H or F, Y is H, F, Cl, hydroxy, methyl, ethyl, methoxy or ethoxy, and R is hydroxyl, alkoxy, aroxy, or NR 1 R 2 where R 1 is hydrogen, alkyl, or aryl and R 2 is alkyl or aryl, with the proviso that when Y is H, X is F.
Claim 3
Dependent Claim 76 words
The compound of claim 1 wherein the alkoxy group represented by R contains 1 to about 8 carbon atoms, the aroxy group represented by R contains 6 to about 15 carbon atoms, the alkyl groups represented by R 1 and R 2 each contain 1 to about 8 carbon atoms and have 0 to 1 hydroxy substituent, and the aryl groups represented by R 1 and R 2 each contain 6 to about 15 carbon atoms.
Claim 4
Dependent Claim 79 words
The compound of claim 1 wherein the alkoxy group represented by R contains 1 to 4 carbon atoms, the aroxy group represented by R is phenoxy, monohydroxyphenoxy, or monoalkoxyphenoxy where the alkoxy group contains 1 to 4 carbon atoms, the alkyl groups represented by R 1 and R 2 each contain 1 to 4 carbon atoms and have 0 or 1 hydroxy substituent, and the aryl groups represented by R 2 and R 3 are phenyl, 4-hydroxyphenyl, or 4-methoxyphenyl.
Claim 5
Dependent Claim 77 words
The compound of claim 1 where (a) R is ethoxy, X is fluorine, and Y is hydrogen; or (b) R is hydroxy, X is fluorine, and Y is hydrogen; or (c) R is ethoxy, X is hydrogen, and Y is methoxy; or (d) R is hydroxy, X is hydrogen and Y is methoxy; or (e) R is ethoxy, X is hydrogen, and Y is fluorine; or (f) R is hydroxy, X is hydrogen, and Y is fluorine.
Claim 6
Dependent Claim 20 words
A pharmaceutical composition comprising a pharmaceutically effective amount of the compound of claim 1 combined with a pharmaceutically acceptable carrier.
Claim 7
Dependent Claim 32 words
A chemopreventive composition for inhibiting tumor promotion in epithelial cells in a living animal comprising a tumor promotion inhibiting amount of the compound of claim 1 combined with a pharmaceutically acceptable carrier.
Claim 8
Dependent Claim 26 words
A therapeutic composition for treating a nonmalignant skin disorder comprising a therapeutically effective amount of the compound of claim 1 combined with a pharmaceutically acceptable carrier.
Claim 9
Dependent Claim 29 words
A method of inhibiting tumor promotion in epithelial cells of a living animal comprising administering a tumor promotion inhibiting amount of the compound of claim 1 to the animal.
Claim 10
Dependent Claim 11 words
The method of claim 8 where the animal is a human.
Claim 11
Dependent Claim 83 words
The method of claim 8 where the animal is a human and (a) R is ethoxy, X is fluorine, and Y is hydrogen, or (b) R is hydroxy, X is fluorine, and Y is hydrogen, or (c) R is ethoxy, X is hydrogen, and Y is methoxy, or (d) R is hydroxy, X is hydrogen, and Y is methoxy, or (e) R is ethoxy, X is hydrogen, and Y is fluorine, or (f) R is hydroxy, X is hydrogen, and Y is fluorine.
Claim 12
Dependent Claim 27 words
A method of treating a living animal for a nonmalignant skin disorder comprising administering a therapeutically effective amount of the compound of claim 1 to the animal.
Claim 13
Dependent Claim 11 words
The method of claim 11 where the animal is a human.
Claim 14
Dependent Claim 83 words
The method of claim 11 where the animal is a human and (a) R is ethoxy, X is fluorine, and Y is hydrogen, or (b) R is hydroxy, X is fluorine, and Y is hydrogen, or (c) R is ethoxy, X is hydrogen, and Y is methoxy, or (d) R is hydroxy, X is hydrogen, and Y is methoxy, or (e) R is ethoxy, X is hydrogen, and Y is fluorine, or (f) R is hydroxy, X is hydrogen, and Y is fluorine.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-07-29 1989-01-28 1989-07-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-07-29 1993-01-28 1993-07-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-07-29 1997-01-28 1997-07-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag